|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,814.90 INR | -2.44% |
|
-0.59% | +0.87% |
| 01-12 | BOB Capital Markets Upgrades Mphasis to Hold From Sell; Price Target is INR2,852 | MT |
| 01-09 | Mphasis Limited Announces Board Changes | CI |
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 10.75 | 11.33 | 11.79 | 8.98 | 9.34 | |||||
Return on Total Capital | 13.16 | 14.36 | 15.34 | 11.46 | 11.95 | |||||
Return On Equity % | 19.7 | 21.25 | 22.02 | 18.59 | 18.48 | |||||
Return on Common Equity | 19.7 | 21.25 | 22.02 | 18.59 | 18.48 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 42.09 | 41.08 | 41.38 | 40.2 | 42.67 | |||||
SG&A Margin | 0.72 | 0.52 | 0.51 | 0.52 | 0.47 | |||||
EBITDA Margin % | 17.59 | 16.27 | 16.27 | 15.42 | 17.18 | |||||
EBITA Margin % | 16.12 | 15.55 | 15.5 | 14.68 | 16.59 | |||||
EBIT Margin % | 16.06 | 15.27 | 15.28 | 13.92 | 15.25 | |||||
Income From Continuing Operations Margin % | 12.52 | 11.96 | 11.87 | 11.71 | 11.96 | |||||
Net Income Margin % | 12.52 | 11.96 | 11.87 | 11.71 | 11.96 | |||||
Net Avail. For Common Margin % | 12.52 | 11.96 | 11.87 | 11.71 | 11.96 | |||||
Normalized Net Income Margin | 9.94 | 9.6 | 9.5 | 8.28 | 9.25 | |||||
Levered Free Cash Flow Margin | 8.97 | 10.77 | 11.34 | 13.79 | 14.15 | |||||
Unlevered Free Cash Flow Margin | 9.38 | 11.16 | 11.78 | 14.54 | 14.88 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.07 | 1.19 | 1.23 | 1.03 | 0.98 | |||||
Fixed Assets Turnover | 12.28 | 14.39 | 14.86 | 13.89 | 16.2 | |||||
Receivables Turnover (Average Receivables) | 5.28 | 5.62 | 5.54 | 5.25 | 5.34 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 2.4 | 1.96 | 2.13 | 1.58 | 1.57 | |||||
Quick Ratio | 2.19 | 1.85 | 2.03 | 1.47 | 1.47 | |||||
Operating Cash Flow to Current Liabilities | 0.68 | 0.59 | 0.52 | 0.52 | 0.43 | |||||
Days Sales Outstanding (Average Receivables) | 69.16 | 64.94 | 65.84 | 69.67 | 68.33 | |||||
Average Days Payable Outstanding | 40.94 | 37.44 | 38.66 | 38.31 | 39.75 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 18.1 | 18.03 | 13.27 | 27.16 | 19.61 | |||||
Total Debt / Total Capital | 15.32 | 15.28 | 11.71 | 21.36 | 16.4 | |||||
LT Debt/Equity | 8.23 | 8.41 | 8.59 | 7.68 | 6.06 | |||||
Long-Term Debt / Total Capital | 6.97 | 7.13 | 7.58 | 6.04 | 5.07 | |||||
Total Liabilities / Total Assets | 30.56 | 35.45 | 31.65 | 37.76 | 35.41 | |||||
EBIT / Interest Expense | 24.62 | 24.55 | 21.68 | 11.49 | 13.12 | |||||
EBITDA / Interest Expense | 28.05 | 28.13 | 24.77 | 13.9 | 15.92 | |||||
(EBITDA - Capex) / Interest Expense | 26.06 | 26.51 | 23.61 | 13.32 | 15.55 | |||||
Total Debt / EBITDA | 0.66 | 0.6 | 0.44 | 1.07 | 0.72 | |||||
Net Debt / EBITDA | -0.8 | -0.61 | -0.62 | -0.46 | -0.57 | |||||
Total Debt / (EBITDA - Capex) | 0.71 | 0.63 | 0.46 | 1.11 | 0.73 | |||||
Net Debt / (EBITDA - Capex) | -0.86 | -0.65 | -0.65 | -0.48 | -0.59 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 9.94 | 23.03 | 15.36 | -3.77 | 7.17 | |||||
Gross Profit, 1 Yr. Growth % | 4.38 | 20.36 | 16.2 | -6.5 | 13.76 | |||||
EBITDA, 1 Yr. Growth % | 8.93 | 18.98 | 15.37 | -8.8 | 19.42 | |||||
EBITA, 1 Yr. Growth % | 10.2 | 18.67 | 15.03 | -8.88 | 21.15 | |||||
EBIT, 1 Yr. Growth % | 10.03 | 17.02 | 15.43 | -12.34 | 17.43 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 2.7 | 17.59 | 14.47 | -5.07 | 9.47 | |||||
Net Income, 1 Yr. Growth % | 2.7 | 17.59 | 14.47 | -5.07 | 9.47 | |||||
Normalized Net Income, 1 Yr. Growth % | 8.86 | 18.8 | 14.2 | -16.09 | 19.62 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 2.12 | 17.35 | 14.23 | -5.26 | 9.2 | |||||
Accounts Receivable, 1 Yr. Growth % | 5.7 | 24.81 | 10.68 | -6.71 | 18.35 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -2.29 | 12.48 | 11.02 | -4.3 | -12.13 | |||||
Total Assets, 1 Yr. Growth % | 7.37 | 14.44 | 7.93 | 21.71 | 5.49 | |||||
Tangible Book Value, 1 Yr. Growth % | 19.06 | -5.78 | 19.34 | -14.19 | 12.88 | |||||
Common Equity, 1 Yr. Growth % | 11.96 | 6.38 | 14.28 | 10.84 | 9.48 | |||||
Cash From Operations, 1 Yr. Growth % | 10.11 | 17.96 | -14.8 | 49.11 | -12.59 | |||||
Capital Expenditures, 1 Yr. Growth % | 0.04 | -4.87 | -5.73 | -17.19 | -34 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -16.84 | 28.38 | 21.4 | 27.04 | 10.01 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -17.08 | 27.96 | 21.72 | 28.59 | 9.64 | |||||
Dividend Per Share, 1 Yr. Growth % | 8.57 | 21.05 | 8.7 | 10 | 3.64 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 12.14 | 16.3 | 19.13 | 5.36 | 1.55 | |||||
Gross Profit, 2 Yr. CAGR % | 9.2 | 11.94 | 18.26 | 4.23 | 3.13 | |||||
EBITDA, 2 Yr. CAGR % | 14.8 | 11.32 | 17.16 | 2.57 | 4.36 | |||||
EBITA, 2 Yr. CAGR % | 11.97 | 14.36 | 16.83 | 2.38 | 5.06 | |||||
EBIT, 2 Yr. CAGR % | 11.84 | 13.47 | 16.22 | 0.59 | 1.46 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 6.47 | 9.89 | 16.02 | 4.24 | 1.94 | |||||
Net Income, 2 Yr. CAGR % | 6.47 | 9.89 | 16.02 | 4.24 | 1.94 | |||||
Normalized Net Income, 2 Yr. CAGR % | 9.7 | 13.72 | 16.48 | -2.11 | 0.19 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 7.75 | 9.47 | 15.78 | 4.03 | 1.72 | |||||
Accounts Receivable, 2 Yr. CAGR % | 0.84 | 14.86 | 17.53 | 1.62 | 5.08 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 153.52 | 4.83 | 11.75 | 3.07 | -8.3 | |||||
Total Assets, 2 Yr. CAGR % | 12.92 | 10.85 | 11.14 | 14.62 | 13.31 | |||||
Tangible Book Value, 2 Yr. CAGR % | 15.76 | 5.91 | 6.04 | 1.19 | -1.58 | |||||
Common Equity, 2 Yr. CAGR % | 11.5 | 9.13 | 10.26 | 12.55 | 10.16 | |||||
Cash From Operations, 2 Yr. CAGR % | 23.76 | 13.96 | 0.25 | 12.71 | 14.16 | |||||
Capital Expenditures, 2 Yr. CAGR % | 21.91 | -2.45 | -5.3 | -11.65 | -26.07 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 20.57 | 10.83 | 24.84 | 19.18 | 18.22 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 22.18 | 10.18 | 24.8 | 20.26 | 18.73 | |||||
Dividend Per Share, 2 Yr. CAGR % | 18.63 | 14.64 | 14.71 | 9.35 | 6.77 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 14.1 | 15.66 | 15.98 | 10.95 | 5.96 | |||||
Gross Profit, 3 Yr. CAGR % | 14.48 | 12.7 | 13.34 | 9.35 | 7.32 | |||||
EBITDA, 3 Yr. CAGR % | 18.13 | 14.45 | 12.66 | 7.77 | 7.91 | |||||
EBITA, 3 Yr. CAGR % | 16.32 | 14.16 | 14.58 | 7.54 | 8.29 | |||||
EBIT, 3 Yr. CAGR % | 16.33 | 13.54 | 14.12 | 5.79 | 5.92 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 12.68 | 10.06 | 11.4 | 8.51 | 5.96 | |||||
Net Income, 3 Yr. CAGR % | 13.26 | 10.06 | 11.4 | 8.51 | 5.96 | |||||
Normalized Net Income, 3 Yr. CAGR % | 14.9 | 12.65 | 13.88 | 4.41 | 4.66 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 14.2 | 10.86 | 11.04 | 8.29 | 5.73 | |||||
Accounts Receivable, 3 Yr. CAGR % | 11.8 | 8.26 | 13.45 | 8.82 | 6.91 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 106.11 | 93.36 | 6.86 | 6.12 | -2.27 | |||||
Total Assets, 3 Yr. CAGR % | 10.4 | 13.42 | 9.87 | 14.56 | 11.49 | |||||
Tangible Book Value, 3 Yr. CAGR % | 5.17 | 8.08 | 10.21 | -1.19 | 4.95 | |||||
Common Equity, 3 Yr. CAGR % | 5.99 | 9.77 | 10.82 | 10.45 | 11.51 | |||||
Cash From Operations, 3 Yr. CAGR % | 26.22 | 21.79 | 3.43 | 14.43 | 3.55 | |||||
Capital Expenditures, 3 Yr. CAGR % | 56.83 | 12.24 | -3.55 | -9.44 | -19.83 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 10.41 | 29.01 | 14.25 | 22.17 | 16.04 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 11.59 | 29.77 | 13.9 | 22.77 | 16.61 | |||||
Dividend Per Share, 3 Yr. CAGR % | 23.86 | 19.43 | 12.62 | 13.12 | 7.41 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 9.84 | 14.51 | 16.08 | 11.43 | 9.98 | |||||
Gross Profit, 5 Yr. CAGR % | 12.1 | 15.77 | 15.92 | 9.23 | 9.14 | |||||
EBITDA, 5 Yr. CAGR % | 13.66 | 14.97 | 16.69 | 9.54 | 9.26 | |||||
EBITA, 5 Yr. CAGR % | 13.18 | 14.92 | 16.53 | 9.29 | 10.67 | |||||
EBIT, 5 Yr. CAGR % | 14.96 | 15.48 | 16.29 | 8.17 | 8.88 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 12.13 | 12.14 | 14 | 7.69 | 7.51 | |||||
Net Income, 5 Yr. CAGR % | 14.02 | 12.57 | 14.36 | 7.69 | 7.51 | |||||
Normalized Net Income, 5 Yr. CAGR % | 11.08 | 13.02 | 15.53 | 6.5 | 8.19 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 14.56 | 14.54 | 14.83 | 8.07 | 7.21 | |||||
Accounts Receivable, 5 Yr. CAGR % | 9.02 | 16.87 | 14.06 | 5.55 | 10.02 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 54.41 | 53.05 | 61.34 | 50.34 | 0.51 | |||||
Total Assets, 5 Yr. CAGR % | 4.85 | 8.01 | 10.69 | 13.9 | 11.23 | |||||
Tangible Book Value, 5 Yr. CAGR % | -0.02 | -1.41 | 5.52 | 5.27 | 5.33 | |||||
Common Equity, 5 Yr. CAGR % | 2.2 | 2.45 | 7.68 | 10.87 | 10.56 | |||||
Cash From Operations, 5 Yr. CAGR % | 14.76 | 20.9 | 15.11 | 18.08 | 7.6 | |||||
Capital Expenditures, 5 Yr. CAGR % | -0.19 | 0.32 | 28.18 | 1.99 | -13.28 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 81.4 | 25.73 | 19.27 | 24.99 | 13.93 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 72.62 | 26.09 | 19.88 | 25.88 | 14 | |||||
Dividend Per Share, 5 Yr. CAGR % | 13.7 | 22.03 | 20.11 | 15.29 | 10.25 |
- Stock Market
- Equities
- MPHASIS Stock
- Financials Mphasis Limited
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















